Labiotech article picture

May 06, 2021

Labiotech discussing our proactive approach 

Victor Kotsev has evaluated a broad range of initiatives following the COVID-19 pandemic. He also highlights Leyden Labs' proactive approach toward viral diseases amongst a range of vaccine and treatment options. To read the full article, click here

LL-Blue

OUR NEW APPROACH  |  OUR TEAM  |  JOIN OUR MISSION   |  NEWS  |  CAREERS  

Contact

Media inquiries

Stay updated

Leyden Laboratories B.V.

Leiden Laboratory
Emmy Noetherweg 2
2333 BK  Leiden
The Netherlands


Leyden Laboratories Co.

Boston Laboratory
201 Dexter Avenue
Watertown
MA 02472
United States


Leyden Labs, S.L.

Granada Office
Avda. del Conocimiento 41.A210
Centro de Empresas
Parque Tecnológico de la Salud
18016 Granada
Spain


© Leyden Labs, 2023  |  Privacy Statement  |  Design by Ape to Zebra

Back to top Arrow